The New Math Of Fuel Value: Why Smart Drivers Look Beyond Pump Price

Caltex puts engine cleanliness, fuel quality, and dependable performance at the center of its approach to helping drivers maximize every refill.

What’s In Store At Noel Bazaar 2026: A Modern Paskong Pinoy Experience

Noel Bazaar 2026 brings together holiday shopping, Filipino Christmas traditions, live performances, and family activities across two venues.

From Access To Agency: How Tala’s Philippine Experience Is Shaping Its ASEAN Vision

Tala is using nearly a decade of experience in the Philippines to shape its broader vision for responsible credit access across ASEAN.

Nestlé Group CEO Underscores The Strategic Importance Of The Philippines To The Company’s Growth

Nestlé Group CEO Philipp Navratil highlights the Philippines as one of the company’s most important growth markets worldwide.

WHO To Test 3 New Drugs For Covid-19 Treatment

Three new drugs for Covid-19 are under trials, the WHO announced Wednesday.

WHO To Test 3 New Drugs For Covid-19 Treatment

37
37

How do you feel about this story?

Express Your Reaction
Like
Love
Haha
Wow
Sad
Angry

The World Health Organization (WHO) on Wednesday announced that it will test three new drugs for Covid-19, which will involve thousands of researchers at more than 600 hospitals in 52 countries.

According to a press release issued by WHO, the three new drugs are artesunate, a treatment for severe malaria; imatinib, a drug for certain cancers; and infliximab, a treatment for immune system disorders such as Crohn’s Disease.

These therapies were selected by an independent expert panel for their potential in reducing the risk of death in hospitalized Covid-19 patients, and they were donated for the trial by their manufacturers, WHO said.

“Finding more effective and accessible therapeutics for Covid-19 patients remains a critical need, and WHO is proud to lead this global effort,” WHO Director-General Tedros Adhanom Ghebreyesus said.

In its previous efforts, WHO has tested four drugs, namely remdesivir, hydroxychloroquine, lopinavir and interferon, and the initial results showed that they had little or no effect on hospitalized patients with Covid-19. (PNA)